Anastomosis Devices Market Growth, Trends & Forecast 2025-2033

 

IMARC Group’s report titled “Anastomosis Devices Market Report by Type (Surgical Staplers, Surgical Sutures, Automated Suturing Devices, Surgical Sealants and Adhesives), Application (Gastrointestinal Surgeries, Cardiovascular and Thoracic Surgeries, and Others), End User (Hospitals, Ambulatory Surgical Centers and Clinics, and Others), and Region 2025-2033”, The global anastomosis devices market size reached USD 3.6 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 6.4 Billion by 2033, exhibiting a growth rate (CAGR) of 6% during 2025-2033.

Factors Affecting the Growth of the Anastomosis Devices Industry:

• Increasing Prevalence of Chronic Diseases:

This condition often necessitates coronary artery bypass graft (CABG) surgeries, where anastomosis devices are crucial for connecting blood vessels. Similar procedures requiring anastomosis devices are performed to restore blood flow in the limbs affected by this disease. Surgical resection of tumors in colorectal cancer often involves anastomosis to reconnect the bowel. Conditions like Crohn’s disease and ulcerative colitis may require surgical intervention, involving bowel resection and anastomosis.

• Technological Innovations:

Advancements in minimally invasive techniques allow for smaller incisions and greater precision, reducing the risk of complications and improving recovery times. Anastomosis devices designed for MIS are in high demand. The development of laparoscopic and robotic-assisted surgical systems has increased the accuracy and control during anastomosis, leading to better patient outcomes. New materials that are biocompatible and biodegradable reduce the risk of adverse reactions and the need for follow-up surgeries to remove the devices.

• Aging Population:

Elderly individuals are more prone to cardiovascular diseases such as coronary artery disease, which often require surgical interventions involving anastomosis devices for procedures like coronary artery bypass grafting (CABG). Conditions like colorectal cancer and diverticulitis, which are more common in older adults, often necessitate surgeries where anastomosis devices are used to reconnect tissues. The aging population tends to have a higher rate of surgeries due to the increased prevalence of age-related health issues. This leads to a greater demand for surgical procedures that require anastomosis devices.

Grab a sample PDF of this report: https://www.imarcgroup.com/anastomosis-devices-market/requestsample

Leading Companies Operating in the Global Anastomosis Devices Industry:

• Artivion Inc.

• B. Braun Melsungen AG (B. Braun Holding GmbH & Co. KG)

• Becton, Dickinson and Company

• Getinge AB

• Intuitive Surgical Inc.

• Johnson & Johnson

• Meril Life Sciences Pvt. Ltd.

• Peters Surgical

• Synovis Micro Companies Alliance Inc. (Baxter International Inc.)

Anastomosis Devices Market Report Segmentation:

By Type:

• Surgical Staplers

  • Manual

  • Powered

• Surgical Sutures

  • Absorbable Sutures

    • Synthetic Sutures

    • Natural Sutures

  • Non-absorbable Sutures

    • Polypropylene

    • Nylon

    • Stainless Steel

    • Others

• Automated Suturing Devices

  • Disposable

  • Reusable

• Surgical Sealants and Adhesives

  • Natural/Biological

    • Fibrin-based

    • Collagen-based

    • Albumin-based

  • Synthetic and Semisynthetic

    • PEG Hydrogel-based

    • Cyanoacrylate-based

    • Others

Surgical staplers represent the largest segment due to their widespread adoption in various surgical procedures for their efficiency, speed, and reliability compared to traditional suturing techniques.

By Application:

• Gastrointestinal Surgeries

• Cardiovascular and Thoracic Surgeries

• Others

Cardiovascular and thoracic surgeries account for the majority of the market share because of the high prevalence of cardiovascular diseases requiring complex surgical interventions that heavily utilize anastomosis devices.

By End User:

• Hospitals

• Ambulatory Surgical Centers and Clinics

• Others

Hospitals hold the biggest market share as they perform the majority of surgical procedures and are equipped with the necessary infrastructure and expertise to use advanced anastomosis devices.

Regional Insights:

• North America (United States, Canada)

• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)

• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)

• Latin America (Brazil, Mexico, Others)

• Middle East and Africa

North America enjoys the leading position in the anastomosis devices market owing to its advanced healthcare infrastructure, high healthcare spending, and significant adoption of innovative surgical technologies.

Global Anastomosis Devices Market Trends:

The development of advanced surgical staplers, bioabsorbable anastomosis devices, and robotic-assisted systems is driving market growth by improving surgical outcomes and reducing recovery times. The shift towards minimally invasive techniques, which require precise and efficient anastomosis devices, is boosting the demand for these products due to benefits like reduced patient trauma and quicker recovery. The growing prevalence of cardiovascular diseases, gastrointestinal disorders, and other chronic conditions necessitating surgical interventions is catalyzing the demand for anastomosis devices globally.

Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us

IMARC Group134 N 4th St. Brooklyn, NY 11249, USA Email: sales@imarcgroup.comTel No:(D) +91 120 433 0800United States: +1–631–791–1145